Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
Percutaneous revascularisation has evolved dramatically in the past few decades. The approach to the management of ischaemic heart disease has changed due to the development of new devices and techniques as well as the availability of new drugs and treatment strategies. Its use in combination with a...
Enregistré dans:
Auteurs principaux: | Tamara García Camarero, José M de la Torre Hernández |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ee6142e66f9d4614b35c8e41a8d1ecd8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
par: Despoina-Rafailia Benetou, et autres
Publié: (2021) -
Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation
par: Despoina-Rafailia Benetou, et autres
Publié: (2021) -
Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
par: Charalampos Varlamos, et autres
Publié: (2021) -
Antithrombotic Therapy in Chronic Total Occlusion Interventions
par: Iosif Xenogiannis, et autres
Publié: (2021) -
Antithrombotic Therapy after Venous Stent Placement
par: Nicholas Xiao, et autres
Publié: (2020)